Previous Article | Next Article ![]()
Journal of Bacteriology, January 2005, p. 747-751, Vol. 187, No. 2
0021-9193/05/$08.00+0 doi:10.1128/JB.187.2.747-751.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
and
Duncan C. Krause*
Department of Microbiology, University of Georgia, Athens, Georgia
Received 30 August 2004/ Accepted 18 October 2004
|
|
|---|
|
|
|---|
Passage of M. pneumoniae in broth culture leads to the spontaneous loss of cytadherence at a high frequency (11). One such cytadherence mutant, designated III-4, lacks the three virulence-specific proteins A, B, and C (72, 85, and 37 kDa, respectively), originally described by comparing virulent and avirulent strains of M. pneumoniae by two-dimensional polyacrylamide gel electrophoresis (PAGE) (6). Proteins B and C appear to correspond to the 90- and 40-kDa products of MPN142 (orf6), respectively. The predicted product of MPN142 is 130 kDa, but antisera raised against recombinant protein fragments derived from regions at the 5' and 3' ends of MPN142 detected proteins of 40- and 90-kDa, respectively, in wild-type M. pneumoniae (22), indicating that the gene product undergoes a processing event (14). P90 and P40 are integral membrane proteins located at the attachment organelle in wild-type M. pneumoniae (3) in proximity to P1 (15). In mutant III-4 and the apparently similar noncytadherent strain M5 (13), which also lacks the 90- and 40-kDa proteins, P1 is located at a focus in one or more but not all branched structures (19, 20). Mutants III-4 and M5 and an avirulent high broth-passage strain (6, 12, 16) lack the 90- and 40-kDa proteins detected with antibodies to the MPN142 gene products, suggesting that B and C correspond to the 90- and 40-kDa proteins, respectively. Despite the availability of the M. pneumoniae genome sequence, the identity of protein A or its gene remains unknown.
The genetic defect responsible for the cytadherence phenotype of mutant III-4 has not been previously determined. Here we identify a frameshift mutation in MPN142 of mutant III-4 and demonstrate that a spontaneously arising, cytadhering revertant of III-4 (III-4-R1) restores the MPN142 reading frame. Furthermore, a recombinant wild-type MPN142 was engineered and introduced into mutant III-4, restoring a wild-type phenotype.
Using primers corresponding to the published genome sequence (7) and genomic DNA from mutant III-4 as templates, regions of MPN142 and flanking sequences were amplified to yield five overlapping PCR fragments. These were cloned into pCRII using a TA cloning kit (Invitrogen, Carlsbad, Calif.) and sequenced for both strands (Integrated Biotech Laboratories, University of Georgia). A direct repeat of the sequence TAAA was identified at nucleotide 14 in the coding sequence of MPN142 in mutant III-4 but not in wild-type M. pneumoniae, causing a frameshift (Fig. 1). This difference from the published sequence was confirmed by repeated amplification and sequencing. The resulting gene encodes a peptide of 98 residues, compared to 1,218 residues for wild-type MPN142.
![]() View larger version (26K): [in a new window] |
FIG. 1. Sequence comparisons of MPN142 of wild-type M. pneumoniae, cytadherence mutant III-4, and revertant III-4-R1. (A) Nucleotide sequence. Nucleotide 1 is the annotated start of the gene. The TAAA acquired in mutant III-4 and the T lost in the reversion of III-4 to III-4-R1 are shown in bold. (B) Deduced amino acid sequence. Dashes show an alignment gap. The ellipsis denotes a break in the representation. The asterisk denotes a translational stop. Note that the order of the strains differs between panels A and B for convenience in alignment.
|
![]() View larger version (91K): [in a new window] |
FIG. 2. Qualitative hemadsorption screening of M. pneumoniae colonies. (A) Wild-type (WT), mutant (III-4), and revertant (III-4-R1). (B) Transformants (III-4 plus pKV258 or pKV264).
|
![]() View larger version (17K): [in a new window] |
FIG. 3. Western immunoblot analysis of wild-type (WT), mutant (III-4), revertant (III-4-R1), and transformant M. pneumoniae lysates. Two independent transformants are shown for each transposon-background combination. Forty micrograms of protein was used per lane. Anti-P90 (upper) and anti-P40 (lower) sera were used at a dilution of 1:1,000.
|
![]() View larger version (112K): [in a new window] |
FIG. 4. Phase-contrast, anti-P1 immunofluorescence, and merged micrographs of M. pneumoniae. (A) Wild-type (WT), mutant (III-4), and revertant (III-4-R1). Due to the poor growth of mutant III-4 and its sparse distribution on the slide, individual cells are shown in separate panels. (B) Mutant III-4 transformed with pKV258 or pKV264. Bar, 2 µm.
|
![]() View larger version (22K): [in a new window] |
FIG. 5. Creation of pKV258 and pKV264. 1. The 7.5-kb SphI-BamHI fragment from pKV208 was subcloned into the corresponding sites of pALTER-1 (Promega). 2. Into this was cloned the 1.5-kb BamHI fragment spanning the 5' end of MPN141. 3. A 7.7-kb BsiWI fragment was removed to reduce the size of the plasmid temporarily for efficient silent mutagenesis. 4. The second and third EcoRI sites in MPN142 were silently changed to GGATTC using an AlteredSites II mutagenesis kit (Promega), and the SphI site was replaced with an MfeI site using complementary synthetic linkers (5'-CAATTGTCATG and 5'-ACAATTGCATG). 5. The resulting 1.4-kb BamHI-MfeI fragment was cloned into the BamHI and EcoRI sites of the Tn4001mod-bearing plasmid pKV74 (5). 6. The 7.7-kb BsiWI fragment was then restored to yield pKV258. To create pKV264, the 4.6-kb BsaBI-StuI fragment in MPN141 was removed to create a massive internal in-frame deletion, as described in the text. B, BamHI; Bi, BsiWI; Bs, BsaBI; E, EcoRI; e, destroyed EcoRI site; S, StuI; Sm/P, SmaI/PmeI junction; M/E, MfeI/EcoRI junction at the former SphI site. Open arrow from Tn4001mod in pKV74 shows the location and direction of the Pout promoter. Note that the inserts are inverted when cloned into Tn4001mod. The figure is not created to scale.
|
Plasmids pKV258 and pKV264 were transformed into wild-type M. pneumoniae and mutant III-4. Transformants were isolated and immunoblot and hemadsorption analyses were performed as previously described (4). Several transformants were examined for each transposon-background combination to control for potential variability associated with the site of transposon insertion. Wild-type levels of P90 and P40 were observed in wild-type and mutant III-4 M. pneumoniae transformed with pKV258 or pKV264 when examined by sodium dodecyl sulfate-PAGE and immunoblotting with P90- or P40-specific antisera; as expected, P90 or P40 were not observed in mutant controls (Fig. 3). The transformants attached to plastic (data not shown), were hemadsorption positive (Fig. 2B), and exhibited a wild-type P1 localization pattern (Fig. 4B). Mutant III-4 transformed with pKV258 had a pronounced extended cellular morphology compared to wild-type M. pneumoniae and mutant III-4 transformed with pKV264 (Fig. 4B). This phenotype was consistent in independent transformants, and we speculated it might be due to the increased gene dosage of MPN141 in mutant III-4 with pKV258. However, when an extra copy of MPN141 without MPN142 was added to wild-type M. pneumoniae, transformant cells appeared normal (data not shown), and the explanation and importance of this observation are not known.
Several lines of evidence suggest that the virulence-specific proteins B and C described originally by Hansen et al. (6) correspond to the P90 and P40 protein products of MPN142, but a definitive relationship has not been previously established. Thus, the possibility remained that the cytadherence defect in mutant III-4 for example was not the direct result of the absence of proteins B and C. Furthermore, the inability to identify the gene for protein A has contributed some measure of uncertainty regarding cause and effect. Here we demonstrate conclusively that the genetic defect responsible for the loss of cytadherence in mutant III-4 is a frameshift in the gene MPN142. This defect can be rescued by a second-site mutation that restores the MPN142 reading frame or by complementation with the wild-type MPN142 allele.
Our attempts to determine the identity of the protein A spot, which is seen in wild-type M. pneumoniae only by two-dimensional PAGE using isoelectric focusing in the first dimension (6) and is absent in mutant III-4 (11), were unsuccessful. While the identity of protein A remains unclear, we speculate that its loss may be a secondary consequence of the mutation in MPN142, perhaps in the same manner that loss of cytadherence-associated protein HMW2 is accompanied by reduced steady-state levels of HMW1, HMW3 (17), and P65 (8).
Finally, the construction of pKV258 and pKV264 and the ability to express their recombinant proteins in and complement a mutant background provide opportunities for more-detailed studies into the nature of proteins B, C, and P1. For example, recombinant derivatives of each can be examined in wild-type and mutant M. pneumoniae for structure-function analyses of these proteins, their interrelationships, and the mechanisms of their processing and maturation.
This work was supported by the Public Health Service research grant AI23362 from the National Institute of Allergy and Infectious Diseases (D.C.K.) and a National Science Foundation Research Training Grant in Prokaryotic Diversity (NSF BIR9413235) (R.H.W.).
Present address: Infectious Diseases Research, Centocor, Inc., Malvern, PA 19355. ![]()
|
|
|---|
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»